Immunodiagnostic Systems, the Newcastle based niche Diagnostics Company, announced in the August update that the sales and marketing director is stepping down from the board and taking on a new role within the group.

The new sales and marketing director, Lynda Merrill,comes from QIAGEN, where she was VP, Molecular Diagnostics Sales for the Europe, Middle East, Africa and Asia region. At her prior employer, Gen-Probe, where she was VP for Industrial Relationships and VP of World Wide Marketing and Sales, she implemented global marketing and pricing strategies and grew product revenues from $96 million in 1999 to $223 million in 2003.

The IDH share price has increased by 41% over the last year.

Immunodiagnostic Systems Holdings Plc is currently graded B by LCF Research. To learn more, follow the link.

Unlock the rest of this article with a 14 day trial

or Unlock with your email

Already have an account?
Login here